Showing results (2191-2200 of 2,307) with videos related to

Sort By:
Pageof 231
Cell Host & Microbe|May 12, 2017
Global Reprogramming of Host Kinase Signaling in Response to Fungal InfectionAseem Pandey, Sheng Li Ding, Qing-Ming Qin, et al.
Cell Genomics|April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targetsIga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Eclinicalmedicine|June 3, 2026
Electroacupuncture for knee osteoarthritis: a multicentre randomised controlled trial assessing symptomatic and structural efficacyMinghui Hang, Yubo Shao, Wang Lu, et al.
JAMA|June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical TrialJamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Cell Systems|December 9, 2015
Optimizing cancer genome sequencing and analysisMalachi Griffith, Christopher A Miller, Obi L Griffith, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
The Journal of Investigative Dermatology|October 1, 2014
The genomic landscape of childhood and adolescent melanomaCharles Lu, Jinghui Zhang, Panduka Nagahawatte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) NetworkAnne Lr Schuster, Norah L Crossnohere, Melinda Bachini, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Pageof 231